Dianthus Therapeutics (DNTH) Other Non-Current Assets (2017 - 2025)

Dianthus Therapeutics' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $9.7 million for Q4 2025.

• In Q4 2025, Other Non-Current Assets rose 0.9% year-over-year to $9.7 million; the TTM figure through Dec 2025 stood at $9.7 million (up 0.9% YoY), while the FY2025 annual figure was $9.7 million, up 0.9% from the prior year.
• Other Non-Current Assets for Q4 2025 stood at $9.7 million, up from $9.3 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $9.7 million in Q4 2025, with the low at $60000.0 in Q3 2022.
• The 5-year median for Other Non-Current Assets is $1.5 million (2021), against an average of $2.5 million.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets plunged 96.63% in 2022, then surged 13810.61% in 2025.
• Dianthus Therapeutics' Other Non-Current Assets stood at $1.8 million in 2021, then plunged by 93.2% to $121000.0 in 2022, then surged by 853.72% to $1.2 million in 2023, then soared by 734.4% to $9.6 million in 2024, then gained by 0.9% to $9.7 million in 2025.
• Business Quant data shows DNTH's Other Non-Current Assets at $9.7 million in Q4 2025, $9.3 million in Q3 2025, and $9.2 million in Q2 2025.